Wells Fargo & Company Bionano Genomics, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$0.57 - $1.16 $29,055 - $59,130	-50,975 Reduced 90.09%	5,610 $3,000
Q1 2023 May 12, 2023	BUY	$1.06 - $1.97 $55,846 - $103,789	52,685 Added 1350.9%	56,585 $62,000
Q4 2022 Feb 13, 2023	SELL	$1.4 - $25.4 $1,854 - $33,655	-1,325 Reduced 25.36%	3,900 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.36 - $36.0 $2,106 - $210,600	-5,850 Reduced 52.82%	5,225 $9,000
Q2 2022 Aug 12, 2022	SELL	$12.3 - $27.3 $1.89 Million - $4.2 Million	-153,791 Reduced 93.28%	11,075 $15,000
Q1 2022 May 16, 2022	SELL	$16.6 - $32.3 $1.67 Million - $3.24 Million	-100,341 Reduced 37.83%	164,866 $425,000
Q4 2021 Feb 14, 2022	BUY	$29.9 - $61.2 $1.44 Million - $2.95 Million	48,151 Added 22.18%	265,207 $793,000
Q3 2021 Nov 15, 2021	BUY	$51.4 - $68.2 $10.6 Million - $14 Million	205,613 Added 1796.85%	217,056 $1.2 Million
Q2 2021 Aug 16, 2021	SELL	$44.1 - $84.0 $1.21 Million - $2.31 Million	-27,492 Reduced 70.61%	11,443 $84,000
Q1 2021 May 13, 2021	BUY	$47.0 - $155.7 $1.55 Million - $5.13 Million	32,938 Added 549.24%	38,935 $315,000
Q4 2020 Feb 09, 2021	BUY	$4.8 - $30.8 $24,710 - $158,558	5,148 Added 606.36%	5,997 $18,000
Q3 2020 Nov 05, 2020	BUY	$4.7 - $8.9 $3,191 - $6,043	679 Added 399.41%	849 $1,000
Q2 2020 Aug 13, 2020	BUY	$2.6 - $5.7 $197 - $433	76 Added 80.85%	170 $0
Q1 2020 May 14, 2020	BUY	$3.9 - $12.7 $366 - $1,193	94 New	94 $0

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $81.2M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.